Actively Recruiting
Fusing Rapid-cycle Testing and Adaptive Trial Designs to Translate and Individualize Behavioral Interventions for Adults with Type 1 Diabetes Distress
Led by University of North Carolina, Chapel Hill · Updated on 2025-10-29
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of North Carolina, Chapel Hill
Lead Sponsor
A
American Diabetes Association
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating two different virtual group-based behavioral interventions to reduce diabetes distress, which includes the emotional burdens and challenges faced by adults living with type 1 diabetes. This pragmatic trial uses a precision medicine design called a Sequential Multiple Assignment Randomized Trial (SMART) to compare an emotions-focused approach and a problem-solving approach. The study aims to find the most effective methods to help adults 30 years and older manage diabetes distress and to personalize treatments based on individual responses. Participants will be randomly assigned to one of two 5-week primary virtual interventions: ReCharge, which focuses on Acceptance and Commitment Therapy (ACT) to lessen emotional distress, or TakeCharge, which focuses on problem-solving skills to improve diabetes management. After completing the primary intervention, participants' responses will be assessed through surveys. Those who do not respond will be re-randomized to one of two supplementary 5-week interventions involving three individualized virtual sessions, allowing further practice of either the emotional or problem-solving methods. During the 12-week study period, all interventions and assessments are conducted virtually. Participants will complete various surveys and assessments at baseline, 6 weeks, and 12 weeks to measure changes in diabetes distress, perceived stress, quality of life, confidence in diabetes management, self-compassion, hypoglycemic attitudes, and blood sugar control through HbA1c and continuous glucose monitoring metrics. The study also gathers feedback to improve intervention implementation and aims to support future wider integration of these approaches into routine diabetes care.
CONDITIONS
Brief Title
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 30 years and older
- Diagnosed with type 1 diabetes or latent autoimmune diabetes managed as type 1 diabetes
- Elevated diabetes distress with a score of 2.0 or higher on the T1-DDAS core scale
- Able to speak and understand English
You will not qualify if you...
- Do not receive diabetes care at UNC Endocrinology at Eastowne
- Unable to commit to scheduled weekly virtual sessions
- Diagnosis of major medical or psychiatric conditions that prevent participation
- Dementia or cognitive impairments affecting memory or information retention
- Visual or hearing impairments interfering with group participation
- Receiving inpatient psychiatric treatment or history of suicide attempt within the past 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (virtual)
Duration - 5 weeks
Participants are randomized to one of two 5-week virtual group interventions to reduce diabetes distress: an emotions-focused approach (ReCharge) or a problem-solving approach (TakeCharge). Weekly virtual group sessions include assignments and group discussions to practice new skills.
Weekly virtual group sessions
Duration - 5 weeks
Participants who do not respond to the initial intervention are re-randomized to a supplementary 5-week virtual intervention with three individualized virtual sessions to further practice either the ReCharge or TakeCharge curriculum.
3 individualized virtual sessions
Trial Site Locations
Total: 1 location
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599
Actively Recruiting
Research Team
A
Angela Fruik, MPH, RD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here